Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 28Burkitt Lymphoma 20Leukemia, Myeloid, Acute 11Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7Myeloproliferative Disorders 5Myelodysplastic Syndromes 5Lymphoma, Non-Hodgkin 5Lymphoma, Mantle-Cell 5Lymphoma, Large B-Cell, Diffuse 5Leukemia, Myelomonocytic, Chronic 5Leukemia, Myeloid, Accelerated Phase 5Leukemia, Lymphocytic, Chronic, B-Cell 5Leukemia, Biphenotypic, Acute 5Hodgkin Disease 5Congenital Abnormalities 5Lymphoma, Large-Cell, Anaplastic 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Blast Crisis 4Anemia, Refractory, with Excess of Blasts 4Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Lymphoma 3Hematologic Neoplasms 3Chromosome 5q Deletion Syndrome 3Breast Neoplasms 3Waldenstrom Macroglobulinemia 2Sezary Syndrome 2Recurrence 2Primary Myelofibrosis 2

Interventions

Cytarabine 21fludarabine phosphate 8Busulfan 8Daunorubicin 7Peripheral Blood Stem Cell Transplantation 6Mitoxantrone 6Idarubicin 6Methotrexate 5Gemtuzumab 5Filgrastim 5Etoposide 5Clofarabine 5tipifarnib 4Whole-Body Irradiation 4Vorinostat 4Tacrolimus 4Cyclosporine 4Cyclophosphamide 4Antilymphocyte Serum 4sargramostim 3alvocidib 3Observation 3Mycophenolic Acid 3Flow Cytometry 3Decitabine 3Cytogenetic Analysis 3Azacitidine 3aldesleukin 2Pravastatin 2In Situ Hybridization, Fluorescence 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leukemia, Megakaryoblastic, Acute × merphos × Clear all
NCT01168219 2022-08-04

Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 2 Completed
68 enrolled 11 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡